HRT FINANCIAL LP

Position in MRK — Merck & Co., Inc.

CIK 1475597 NEW YORK, NY

Position in MRK

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$17,168,871

-$47,329,825 QoQ

Shares Held

142,729

-76.7% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $579,743,845 across 13 Drug Manufacturers - General names. MRK ranks #7 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	926,410	$201,484,910
2	BMY	Bristol Myers Squibb Co	2,075,945	$125,906,064
3	AMGN	Amgen Inc	321,715	$113,195,422
4	LLY	ELI LILLY & Co	53,051	$48,794,718
5	GILD	Gilead Sciences, Inc.	270,699	$37,727,319
6	GSK	GSK plc	425,687	$23,493,665
7	MRK	Merck & Co., Inc. This page	142,729	$17,168,871
8	NVS	Novartis AG	24,886	$3,801,336

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,168,871	142,729	-76.7%	Shares	Defined	2026-05-14
2025-12-31	$64,498,696	612,756	+137.4%	Shares	Defined	2026-02-12
2025-09-30	$21,658,891	258,059	-76.8%	Shares	Defined	2025-11-14
2025-06-30	$88,220,099	1,114,453	-29.4%	Shares	Defined	2025-08-14
2024-03-31	$208,216,044	1,577,992	+8951.2%	Shares	Defined	2024-05-13
2023-12-31	$1,900,654	17,434	-77.2%	Shares	Defined	2024-02-09
2023-09-30	$7,855,187	76,301	-39.0%	Shares	Defined	2023-11-13
2022-12-31	$13,869,082	125,003	+127.9%	Shares	Defined	2023-02-10
2022-03-31	$4,501,345	54,861	-96.9%	Shares	Defined	2022-05-16
2021-09-30	$134,357,293	1,788,807	+144.9%	Shares	Defined	2021-11-15
2021-06-30	$56,800,174	730,361	+753.1%	Shares	Defined	2021-08-16
2020-12-31	$6,682,619	85,616	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.